Epilepsy Therapies & Diagnostics Development Symposium (ETDD) Formerly Antiepileptic Drug & Device Trials (AEDD)
Since 1992, researchers from academic epilepsy, governmental agencies such the Food and Drug Administration, the National Institutes of Health, and pharmaceutical and device industry researchers have been meeting on a biennial basis to discuss ways to expedite new epilepsy therapies to patients. These meetings have been exchanges of ideas, discussions of roadblocks to therapeutic development, dialogues about regulatory strategies, and the sharing of successful approaches.
Discussions from prior meetings have led to:
- Implementation of new trial designs
- Important re-analyses and insights drawn from previous epilepsy trials
- Identification of new regulatory pathways, notably the approval of new antiepileptic drugs for monotherapy use
- New therapeutic understandings of clinical trial methodology and analysis to the larger neurological community and to clinicians who ultimately use these therapies
Epilepsy Therapies & Diagnostics Development XVII Symposium (ETDD) will be held May 31-June 2, 2023 at JW Turnberry Isle Hotel, Aventura, FL.
Details can be found on our website: https://etddtrials.com
Contact Bree DiVentura: diventura@epilepsyconsortium.org or Tracy DeVito: devito@epilepsyconsortium.org for details
